Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9578 posts found.

images

Roche’s neoadjuvant breast cancer combo therapy shows strong Phase 3 results

March 2, 2017 Research and Development Herceptin, Perjeta, Roche

Roche’s combination treatment of Perjeta (pertuzumab), Herceptin (trasdtuzumab) and chemotherapy met its primary endpoint in a recent Phase 3 study. …
News
scott_smith_252

New COO for Celgene

March 1, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene

Celgene released in a statement that its Chief Operating Officer and President, Jacqualyn “Jackie” Fouse, will retire from her position. …
Appointment

Graham Dunkley chooses Medica’s Pharma Cartons

March 1, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Medica Packaging

Medica Packaging is pleased to announce that Graham Dunkley, most recently of Multi Packaging Solutions (MPS) has joined Medica as …
News
Press release
800px-cocainehydrochloridepowder

Promising anti-cocaine treatment aims for human trials within a year

March 1, 2017 Research and Development University of Cincinnati, cocaine, immunotherapy

Researchers at the University of Cincinnati (UC) have developed a monocloncal antibody designed to treat cocaine addiction; its successful showing …
News
lungs

Asthma drugs may have alternative function as pneumonia treatment

March 1, 2017 Research and Development asthma, influenza, pneumonia

Researchers from the University of Virginia School of Medicine have discovered that two drugs commonly used to treat asthma, Accolate …
News
kitepharma_fullcolor_rgb_1

Kite Pharma climbs on strong data showing in lymphoma trial

March 1, 2017 Research and Development kite pharma, non-Hodgkin lymphoma

Kite Pharma released the news on Rare Diseases Day promising top-line data from a Phase 1/2 trial of its treatment …
News
jakob-riis

Novo Nordisk’s Head of North America resigns

March 1, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, appointment

Novo Nordisk has announced the surprising news that its Executive Vice President, Head of North American Operations Jakob Riis has …
News
keytruda1

NICE knocks back MSD’s Keytruda for lung cancer indication

February 28, 2017 Research and Development, Sales and Marketing MSD, NICE, NSCLC, keytruda

MSD’s immunotherapy drug Keytruda (pembrolizumab) has been knocked back by the National Institute of Health and Care Excellence (NICE) for …
News
world_health_organization_flag

WHO releases list of bacteria that pose greatest threat to humankind

February 28, 2017 Research and Development WHO, antibiotic resistance

The World Health Organisation (WHO) has published a list of the 12 bacteria that are thought to present the largest …
News
janssen_latest_logo_on_sign_closer

EMA recommends expanded indication for Janssen multiple myeloma drug

February 27, 2017 Manufacturing and Production, Research and Development, Sales and Marketing Janssen, darzalex

The European Medicines Agency’s Committee for Medicinal Products for Human Use has given its positive opinion for the use of …
News
lajolla-pharmaceutical-company-ljpc-stock-news

La Jolla finds potential jewel in successful Phase 3 trial

February 27, 2017 Manufacturing and Production, Research and Development La Jolla pharmaceutical

La Jolla Pharmaceutical, a biotech company based in San Diego, US, received a boost to both its shares and its …
News
c5rxfeiwyaez8kv

Moderna Therapeutics instates MIT Treasurer to Board of Directors

February 27, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MIT, Moderna, Moderna Therapeutics

Moderna Therapeutics, a clinical stage biotechnology company, has announced the appointment of Israel Ruiz to the company’s Board of Directors. …
Appointment

Does Trump pose a threat to the FDA’s future?

February 27, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Trump

President Trump’s first month in office made headlines across the industry just as it did in the wider media. Promises …
Feature
merckincweb1

MSD’s investigational cytomegalovirus treatment shows significant promise in Phase 3 trial

February 27, 2017 Research and Development, Sales and Marketing MSD, cytomegalovirus, letermovir

MSD has lifted the curtain on strong Phase 3 results in the development of its investigational antiviral drug letermovir, showing …
News
hand

Assay opens way to autoantibodies treatment for rheumatoid arthritis

February 27, 2017 Research and Development, Sales and Marketing rheumatoid arthritis

A new discovery, conducted by researchers at the NYU Langone Medical Center and the University of Pittsburgh, has pointed towards …
News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026